Rtw Investments »

Cg Oncology shares owned by Rtw Investments

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Rtw Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $18M 414k 43.90

More positions owned by Rtw Investments

Rocket Pharmaceuticals (RCKT)
Immunocore Hldgs Ads (IMCR)
Axsome Therapeutics (AXSM)
Ultragenyx Pharmaceutical (RARE)
Bruker Corporation (BRKR)
Argenx Se Sponsored Adr (ARGX)
ACADIA Pharmaceuticals (ACAD)
Natera (NTRA)
Ptc Therapeutics I (PTCT)
Masimo Corporation (MASI)
Avidity Biosciences Ord (RNA)
Merus N V (MRUS)
Cytokinetics Com New (CYTK)
Apogee Therapeutics (APGE)
Alkermes SHS (ALKS)

View all positions for Rtw Investments

Top funds holding Cg Oncology

Decheng Capital
TCG Crossover Management
Braidwell
BVF
Vanguard Group
BlackRock
Henderson Group
RA Capital Management
Avidity Partners Management
Franklin Resources
Alliancebernstein
State Street Corporation
Cormorant Asset Management
Frazier Life Sciences Management
Perceptive Advisors

View all funds holding Cg Oncology